INTRODUCTION: The increase of multidrug-resistant (MDR) bacteria in healthcare settings is a worldwide concern. Isolation precautions must be implemented to control the significant risk of transmitting these pathogens among patients. Antibiotic decolonization is not recommended because of the threat of increasing antibiotic resistance. However, restoring gut microflora through faecal microbiota transplantation (FMT) is a hopeful solution. PATIENTS AND METHOD: In 2019-2022, FMT was indicated in seven patients of the Spinal Cord Unit at University Hospital Motol who were colonized with MDR bacterial strains. Five patients tested positive for carriage of carbapenemase-producing Enterobacteriaceae, and two were carriers of vancomycin-resistant enterococci. Isolation measures were implemented in all patients. Donor faeces were obtained from healthy, young, screened volunteers. According to local protocol, 200-300 ml of suspension was applied through a nasoduodenal tube. RESULTS: The mean age of the patients was 43 years. The mean length of previous hospital stay was 93.2 days. All patients were treated with broad-spectrum antibiotics for infectious complications before detecting colonisation with MDR bacteria. MDR organism decolonization was achieved in five patients, and consequently, isolation measures could be removed. Colonization persisted in two patients, one of whom remained colonized even after a third FMT. No adverse events were reported after FMT. CONCLUSION: FMT is a safe and effective strategy to eradicate MDR bacteria, even in spinal cord injured patients. FMT can allow relaxation of isolation facilitates, the participation of patients in a complete rehabilitation program, their social integration, and transfer to follow-up rehabilitation centres.

Department of Internal Medicine 2 Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Medical Microbiology 2 Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Orthopaedics and Traumatology 3 Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady Prague Czech Republic

Spinal Cord Unit Department of Rehabilitation and Sports Medicine 2 Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Marston H.D., Dixon D.M., Knisely J.M., Palmore T.N., Fauci A.S. Antimicrobial Resistance. JAMA. 2016;316:1193–1204. doi: 10.1001/jama.2016.11764. PubMed DOI

Abad C., Fearday A., Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect. 2010;76:97–102. doi: 10.1016/j.jhin.2010.04.027. PubMed DOI PMC

Saïdani N., Lagier J.C., Cassir N., Million M., Baron S., Dubourg G., et al. Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities. Int J Antimicrob Agents. 2019;53:355–361. doi: 10.1016/j.ijantimicag.2018.11.014. PubMed DOI

Manges A.R., Steiner T.S., Wright A.J. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review. Infect Dis (Lond) 2016;48:587–592. doi: 10.1080/23744235.2016.1177199. PubMed DOI

Woodworth M.H., Hayden M.K., Young V.B., Kwon J.H. The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions. Open Forum Infect Dis. 2019;6:ofz288. doi: 10.1093/ofid/ofz288. PubMed DOI PMC

Kamada N., Chen G.Y., Inohara N., Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14:685–690. doi: 10.1038/ni.2608. PubMed DOI PMC

Cammarota G., Ianiro G., Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014;48:693–702. doi: 10.1097/MCG.0000000000000046. PubMed DOI

Crum-Cianflone N.F., Sullivan E., Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol. 2015;53:1986–1989. doi: 10.1128/JCM.00820-15. PubMed DOI PMC

Dinh A., Fessi H., Duran C., Batista R., Michelon H., Bouchand F., et al. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. J Hosp Infect. 2018;99:481–486. doi: 10.1016/j.jhin.2018.02.018. PubMed DOI

Battipaglia G., Malard F., Rubio M.T., Ruggeri A., Mamez A.C., Brissot E., et al. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria. Haematologica. 2019;104:1682–1688. doi: 10.3324/haematol.2018.198549. PubMed DOI PMC

Bilinski J., Grzesiowski P., Sorensen N., Madry K., Muszynski J., Robak K., et al. Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study. Clin Infect Dis. 2017;65:364–370. doi: 10.1093/cid/cix252. PubMed DOI

Prang P., Schuld C., Rupp R., Hensel C., Weidner N. Influence of patient isolation due to colonization with multidrug-resistant organisms on functional recovery after spinal cord injury. PLoS One. 2021;16 doi: 10.1371/journal.pone.0249295. PubMed DOI PMC

Elemam A., Rahimian J., Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis. 2009;49:271–274. doi: 10.1086/600042. PubMed DOI

Tosi M., Roat E., Biasi S.D., Munari E., Venturelli S., Coloretti L., et al. Multidrug resistant bacteria in critically ill patients: a step further antibiotic therapy. J. Emerg. Crit. Care. Med. 2018;2:103. doi: 10.21037/jeccm.2018.11.08. DOI

Donskey C.J. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis. 2004;39:219–226. doi: 10.1086/422002. PubMed DOI

Zhang F., Luo W., Shi Y., Fan Z., Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107:1755. doi: 10.1038/ajg.2012.251. ; author reply 1755-1756. PubMed DOI

Stripling J., Rodriguez M. Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases-Clostridium difficile Disease and Beyond. Am J Med Sci. 2018;356:424–432. doi: 10.1016/j.amjms.2018.08.010. PubMed DOI

Lagier J.C., Million M., Fournier P.E., Brouqui P., Raoult D. Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae. J Hosp Infect. 2015;90:173–174. doi: 10.1016/j.jhin.2015.02.013. PubMed DOI

Davido B., Batista R., Michelon H., Lepainteur M., Bouchand F., Lepeule R., et al. Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage? J Hosp Infect. 2017;95:433–437. doi: 10.1016/j.jhin.2017.02.001. PubMed DOI

Jing Y., Yu Y., Bai F., Wang L., Yang D., Zhang C., et al. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome. 2021;9:59. doi: 10.1186/s40168-021-01007-y. PubMed DOI PMC

Schmidt E.K.A., Torres-Espin A., Raposo P.J.F., Madsen K.L., Kigerl K.A., Popovich P.G., et al. Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats. PLoS One. 2020;15 doi: 10.1371/journal.pone.0226128. PubMed DOI PMC

Brechmann T., Swol J., Knop-Hammad V., Willert J., Aach M., Cruciger O., et al. Complicated fecal microbiota transplantation in a tetraplegic patient with severe Clostridium difficile infection. World J Gastroenterol. 2015;21:3736–3740. doi: 10.3748/wjg.v21.i12.3736. PubMed DOI PMC

Yoon Y.K., Suh J.W., Kang E.J., Kim J.Y. Efficacy and safety of fecal microbiota transplantation for decolonisation of intestinal multidrug-resistant microorganism carriage: beyond Clostridioides difficile infection. Ann Med. 2019;51:379–389. doi: 10.1080/07853890.2019.1662477. PubMed DOI PMC

Wang S., Xu M., Wang W., Cao X., Piao M., Khan S., et al. Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One. 2016;11 doi: 10.1371/journal.pone.0161174. PubMed DOI PMC